• Issue

    Hematological Oncology: Volume 29, Issue 3

    i, 111-166
    September 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Issue Information

  • Page: i
  • First Published: 16 September 2011

Reviews

A review of the trends of lymphomas in the equatorial belt of Africa†‡

Emily A. Rogena,  Giulia De Falco,  Karin Schurfeld,  Lorenzo Leoncini, 
  • Pages: 111-115
  • First Published: 30 November 2010

Research Articles

Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children

Jason Yong-Sheng Chan,  Dewa G Ugrasena,  Danny Wai-Kiong Lum,  Yi Lu,  Allen Eng-Juh Yeoh, 
  • Pages: 116-123
  • First Published: 07 September 2010

The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels in chronic myeloid leukaemia patients

Milena S. Marcolino,  Eric Boersma,  Nelma C.D. Clementino,  Maria do Carmo P. Nunes,  Márcia M. Barbosa,  Maria Helena C.R. Silva,  Marcel L. Geleijnse,  Antonio L. Ribeiro, 
  • Pages: 124-130
  • First Published: 22 September 2010

Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan†

Francesco Cicone,  Eleonora Russo,  Andrea Carpaneto,  John O. Prior,  Angelika Bischof Delaloye,  Francesco Scopinaro,  Nicolas Ketterer, 
  • Pages: 131-138
  • First Published: 22 September 2010

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

Felicetto Ferrara,  Tiziana Izzo,  Clelia Criscuolo,  Cira Riccardi,  Assunta Viola,  Rossella Delia,  Antonella Carbone,  Maria Celentano, 
  • Pages: 139-143
  • First Published: 30 November 2010

Letters to the Editor

Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab-associated late onset neutropenia

Evangelia Stalika,  Apostolia Papalexandri,  George Kannelis,  Ioannis Batsis,  Theodora Papadaki,  Achilles Anagnostopoulos,  Kostas Stamatopoulos, 
  • Pages: 144-146
  • First Published: 14 September 2010

Expression of glucocorticoid receptor spliced variants in lymphoma cell lines

Akihiro Ishida,  Yasukazu Hozumi,  Kaoru Goto,  Tsukasa Ito,  Masaru Aoyagi,  Mitsunori Yamakawa, 
  • Pages: 147-150
  • First Published: 07 September 2010

A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma

Giuseppe Todeschini,  Massimiliano Bonifacio,  Cristina Tecchio,  Daniela Dalceggio,  Fabio Benedetti,  Attilio Gabbas,  Giovanni Pizzolo, 
  • Pages: 151-153
  • First Published: 27 September 2010

Genomic profiling of enzastaurin-treated B cell lymphoma RL cells

Monica Civallero,  Maria Cosenza,  Antonino Neri,  Alessia Bari, 
  • Pages: 154-156
  • First Published: 27 October 2010

Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors

Daniel A. Pollyea,  Aparna Raval,  Brenda Kusler,  Jason R. Gotlib,  Ash A. Alizadeh,  Beverly S. Mitchell, 
  • Pages: 157-160
  • First Published: 27 October 2010

Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation

George Papaioannou,  Ioannis Batsis,  Fotis Iordanidis,  Chryssanthi Vadikoliou,  Panagiotis Kaloyannidis,  Achilles Anagnostopoulos,  Anastasia Athanasiadou, 
  • Pages: 161-163
  • First Published: 20 December 2010

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas

Andrea Rinaldi,  Maurilio Ponzoni,  Silvia Uccella,  Davide Rossi,  Gianluca Gaidano,  Fabio Facchetti,  Giancarlo Pruneri,  Maria Grazia Tibiletti,  Carlo Capella,  Emanuele Zucca,  Claudio Doglioni,  Carlo Catapano,  Francesco Bertoni, 
  • Pages: 164-166
  • First Published: 17 March 2011